Position in GRFS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$169,920
-$22,560 QoQ
Shares Held
24,000
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 164 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GAMCO INVESTORS, INC. ET AL holds $86,182,010 across 9 Drug Manufacturers - General names. GRFS ranks #9 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,377 | $32,836,797 | |
| 2 | JNJ |
Johnson & Johnson
|
80,050 | $20,330,298 | |
| 3 | PFE |
Pfizer Inc
|
571,286 | $13,756,566 | |
| 4 | MRK |
Merck & Co., Inc.
|
62,672 | $8,053,352 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
82,671 | $4,763,503 | |
| 6 | ABBV |
AbbVie Inc.
|
13,603 | $3,423,058 | |
| 7 | AMGN |
Amgen Inc
|
4,618 | $1,672,270 | |
| 8 | OGN |
Organon & Co.
|
86,872 | $1,176,246 |
All Filings in GRFS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $169,920 | 24,000 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $192,480 | 24,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $224,400 | 24,000 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $239,040 | 24,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $216,960 | 24,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $170,640 | 24,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $185,895 | 24,986 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $221,875 | 24,986 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $157,661 | 24,986 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $166,906 | 24,986 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $321,368 | 27,800 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $254,092 | 27,800 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $254,648 | 27,800 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $204,886 | 27,800 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $236,300 | 27,800 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $171,248 | 27,800 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $330,264 | 27,800 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $324,704 | 27,800 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $324,547 | 28,900 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $473,568 | 32,414 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $562,382 | 32,414 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $584,229 | 33,790 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $807,801 | 43,807 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $919,671 | 53,007 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $939,141 | 51,488 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,036,968 | 51,488 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||